Cigna Investments Inc. New decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 49.1% during the second quarter, Holdings Channel reports. The firm owned 21,018 shares of the medical research company’s stock after selling 20,285 shares during the period. Cigna Investments Inc. New’s holdings in Agilent Technologies were worth $1,249,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of A. Park National Corp OH boosted its stake in shares of Agilent Technologies by 1.1% in the second quarter. Park National Corp OH now owns 4,077 shares of the medical research company’s stock valued at $242,000 after buying an additional 43 shares during the last quarter. Trust Co. of Vermont boosted its stake in shares of Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after buying an additional 50 shares during the last quarter. Cribstone Capital Management LLC boosted its stake in shares of Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the last quarter. Neuberger Berman Group LLC boosted its stake in shares of Agilent Technologies by 0.9% in the first quarter. Neuberger Berman Group LLC now owns 9,840 shares of the medical research company’s stock valued at $520,000 after buying an additional 91 shares during the last quarter. Finally, HL Financial Services LLC boosted its stake in shares of Agilent Technologies by 1.1% in the second quarter. HL Financial Services LLC now owns 8,957 shares of the medical research company’s stock valued at $531,000 after buying an additional 94 shares during the last quarter.

Shares of Agilent Technologies, Inc. (NYSE A) opened at 59.68 on Thursday. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $61.84. The firm has a 50-day moving average price of $60.17 and a 200-day moving average price of $55.58. The stock has a market cap of $19.18 billion, a PE ratio of 33.55 and a beta of 1.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.10. The business had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.44 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post $2.23 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd were issued a $0.132 dividend. The ex-dividend date was Thursday, June 29th. This represents a $0.53 annualized dividend and a dividend yield of 0.88%. Agilent Technologies’s dividend payout ratio (DPR) is presently 29.78%.

ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/10/agilent-technologies-inc-nysea-shares-sold-by-cigna-investments-inc-new.html.

Several research firms have commented on A. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a report on Tuesday, May 16th. Deutsche Bank AG boosted their target price on Agilent Technologies from $58.00 to $62.00 and gave the stock a “buy” rating in a report on Monday, May 22nd. Cowen and Company boosted their target price on Agilent Technologies from $53.00 to $62.00 and gave the stock a “market perform” rating in a report on Tuesday, May 23rd. Jefferies Group LLC boosted their target price on Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a report on Tuesday, May 23rd. Finally, Robert W. Baird boosted their target price on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a report on Wednesday, May 24th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and an average price target of $60.12.

In related news, CFO Didier Hirsch sold 5,710 shares of Agilent Technologies stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $60.60, for a total value of $346,026.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 50,000 shares of Agilent Technologies stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $59.86, for a total value of $2,993,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 112,608 shares of company stock valued at $6,737,509.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.